Allergic reactions to semaglutide can vary from mild to severe
These questions represent the frontier of knowledge, and the answers, when they come, will refine the prevention and treatment strategies outlined in this guide
The discrepancies could derive from the differences in the experimental dietary fat levels, feeding durations, and cell types studied
Dulaglutide use was associated with a 64% lower risk of OUD (OR = 0.36, 95% CI: 0.20-0.64, p = 0.0006) ( Figure 2 )
Semaglutide and Tirzepatide function by activating GLP-1 and GIP receptors, which are crucial in controlling blood sugar and appetite
They are expected to report their findings later this year, with possible FDA approval in late 2026 or 2027